CONTEMPORARY CLINICAL APPLICATIONS OF COLCHICINE IN CARDIOVASCULAR AND INFLAMMATORY DISEASES

Olga Tatarata; Maja Osuch; Maciej Osuch; Martyna Jaciubek; Amanda Abramowicz; Magdalena Rumin; Anna Kiełboń; Zuzanna Olga Reklewska; Kornelia Domagała; Carmena Luty

doi:10.31435/ijitss.1(49).2026.5042

Authors

Olga Tatarata Military Institute of Aviation Medicine, Warsaw, Mazovia, Poland https://orcid.org/0009-0007-1279-7394
Maja Osuch 4th Military Clinical Hospital with Polyclinic SPZOZ in Wrocław, Wrocław, Poland https://orcid.org/0009-0000-9815-2608
Maciej Osuch 4th Military Clinical Hospital with Polyclinic SPZOZ in Wrocław, Wrocław, Poland https://orcid.org/0009-0009-2399-2878
Martyna Jaciubek Military Institute of Aviation Medicine, Warsaw, Mazovia, Poland https://orcid.org/0009-0002-5520-0002
Amanda Abramowicz Military Institute of Aviation Medicine, Warsaw, Mazovia, Poland https://orcid.org/0009-0004-6674-0594
Magdalena Rumin Military Institute of Aviation Medicine, Warsaw, Mazovia, Poland https://orcid.org/0009-0009-4281-8971
Anna Kiełboń Military Institute of Medicine in Warsaw, Mazovia, Poland https://orcid.org/0009-0004-9028-6395
Zuzanna Olga Reklewska The Military Medical Training Center, Łódź, Poland https://orcid.org/0009-0008-3539-646X
Kornelia Domagała 7th Naval Hospital in Gdańsk, Gdańsk, Poland https://orcid.org/0009-0008-4148-9320
Carmena Luty 118th Military Hospital with Polyclinic SPZOZ in Ełk, Ełk, Poland https://orcid.org/0009-0007-6084-0385

DOI:

https://doi.org/10.31435/ijitss.1(49).2026.5042

Keywords:

Colchicine, Coronary Artery Disease, Pericarditis, Gout, Atrial Fibrillation, Anti-Inflammatory Therapy

Abstract

Colchicine, an alkaloid derived from Colchicum autumnale, has gained renewed attention in contemporary medicine following advances in the understanding of inflammation as a central mechanism in cardiovascular and systemic inflammatory diseases. The objective of this narrative review was to synthesize clinical evidence published between 2015 and 2025 regarding the modern therapeutic applications of colchicine. A structured review of peer-reviewed randomized controlled trials, meta-analyses, and international guideline documents was performed, and findings were qualitatively integrated.

Current rheumatology guidelines confirm colchicine as a first-line therapy for acute gout flares and for prophylaxis during urate-lowering treatment. In cardiology, guideline recommendations support its use in acute and recurrent pericarditis. Large randomized trials in patients with recent myocardial infarction and chronic coronary disease demonstrated a reduction in major adverse cardiovascular events when colchicine was added to contemporary standard therapy, and subsequent meta-analyses further evaluated its role in secondary cardiovascular prevention. Recent European guidelines for chronic coronary syndromes state that low-dose colchicine should be considered in selected patients as part of an event-prevention strategy. Additional studies suggest benefit in inflammation-related atrial fibrillation, particularly in postoperative settings, although gastrointestinal adverse events remain the most frequently reported side effects. Colchicine was also investigated in non-hospitalized patients during the COVID-19 pandemic.

Overall, contemporary evidence supports colchicine as an established anti-inflammatory therapy with validated rheumatologic and expanding cardiovascular applications, while emphasizing the importance of careful patient selection and safety monitoring.

References

Adler, Y., Charron, P., Imazio, M., Badano, L., Barón-Esquivias, G., Bogaert, J., … Tomkowski, W. (2015). 2015 ESC guidelines for the diagnosis and management of pericardial diseases. European Heart Journal, 36(42), 2921–2964. https://doi.org/10.1093/eurheartj/ehv318

Ahmed, M., Hashmi, T. M., Shafiq, A., Ashraf, H., Jain, H., Khanji, M. Y., Providência, R., Chahal, A. A., & Fonarow, G. C. (2025). Efficacy and safety of colchicine in patients with coronary artery disease: An updated meta-analysis of randomized controlled trials. American Heart Journal Open. https://doi.org/10.1016/j.ahjo.2025.100610

Collini, V., De Martino, M., Andreis, A., De Biasio, M., Gaspard, F., Paneva, E., Tomat, M., Deferrari, G. M., Isola, M., & Imazio, M. (2024). Efficacy and safety of colchicine for the treatment of myopericarditis. Heart. Advance online publication. https://doi.org/10.1136/heartjnl-2023-323484

Fiolet, A. T. L., Opstal, T. S. J., Mosterd, A., Eikelboom, J. W., Jolly, S. S., Keech, A. C., … Nidorf, S. M. (2021). Efficacy and safety of low-dose colchicine in patients with coronary disease: A systematic review and meta-analysis. European Heart Journal, 42(28), 2765–2775. https://doi.org/10.1093/eurheartj/ehab115

FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello-Petersen, R., Guyatt, G., Abeles, A. M., … Khanna, D. (2020). 2020 American College of Rheumatology guideline for the management of gout. Arthritis Care & Research, 72(6), 744–760. https://doi.org/10.1002/acr.24180

Giubilato, S., Ciliberti, G., Scicchitano, P., Di Monaco, A., Fortuni, F., Zilio, F., Ciampi, C. M., Cangemi, S., Spinelli, A., Gatto, L., Franchin, L., Cornara, S., Magnesa, M., Sorini Dini, C., Vitale, E., Gasparetto, N., Geraci, G., Rossini, R., Della Bona, R., & Nardi, F. (2025). Colchicine and atherosclerotic coronary artery disease: An updated review. Journal of Clinical Medicine, 14(18), 6396. https://doi.org/10.3390/jcm14186396

Leung, Y. Y., Yao Hui, L. L., & Kraus, V. B. (2015). Colchicine—Update on mechanisms of action and therapeutic uses. Seminars in Arthritis and Rheumatism, 45(3), 341–350. https://doi.org/10.1016/j.semarthrit.2015.06.013

Nidorf, S. M., Fiolet, A. T. L., Mosterd, A., Eikelboom, J. W., Schut, A., Opstal, T. S. J., … Thompson, P. L. (2020). Colchicine in patients with chronic coronary disease. New England Journal of Medicine, 383(19), 1838–1847. https://doi.org/10.1056/NEJMoa2021372

Richette, P., Doherty, M., Pascual, E., Barskova, V., Becce, F., Castañeda, J., … Bardin, T. (2017). 2016 updated EULAR evidence-based recommendations for the management of gout. Annals of the Rheumatic Diseases, 76(1), 29–42. https://doi.org/10.1136/annrheumdis-2016-209707

Tardif, J.-C., Bouabdallaoui, N., L’Allier, P. L., Gaudet, D., Shah, B., Pillinger, M. H., … Roubille, F. (2021). Colchicine for community-treated patients with COVID-19 (COLCORONA): A phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial. The Lancet Respiratory Medicine, 9(8), 924–932. https://doi.org/10.1016/S2213-2600(21)00222-8

Tardif, J.-C., Kouz, S., Waters, D. D., Bertrand, O. F., Diaz, R., Maggioni, A. P., … Roubille, F. (2019). Efficacy and safety of low-dose colchicine after myocardial infarction. New England Journal of Medicine, 381(26), 2497–2505. https://doi.org/10.1056/NEJMoa1912388

Tian, X., Zhang, N., Korantzopoulos, P., Bazoukis, G., Letsas, K. P., Tse, G., & Liu, T. (2024). Efficacy and safety of colchicine for atrial fibrillation prevention: An updated meta-analysis of randomized controlled trials. International Journal of Cardiology. Advance online publication. https://doi.org/10.1016/j.ijcard.2024.132068

Vrints, C., Andreotti, F., Koskinas, K. C., Rossello, X., Adamo, M., Ainslie, J., … ESC Scientific Document Group. (2024). 2024 ESC guidelines for the management of chronic coronary syndromes. European Heart Journal, 45(36), 3415–3537. https://doi.org/10.1093/eurheartj/ehae177

Xie, S., Galimberti, F., Olmastroni, E., Catapano, A. L., & Casula, M. (2025). Colchicine and cardiovascular events: An updated meta-analysis of randomized controlled trials. Journal of Internal Medicine. Advance online publication. https://doi.org/10.1111/joim.20107